ACAD FY 2017 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$125M+620.7% YoY

Gross Profit

$112M89.5% margin

Operating Income

-$292M-234.1% margin

Net Income

-$289M-231.7% margin

EPS (Diluted)

$-2.36

Cash Flow

Operating Cash Flow

-$218M

Free Cash Flow

-$219M

Stock-Based Comp.

$76M

Balance Sheet

Total Assets

$385M

Total Liabilities

$49M

Stockholders' Equity

$335M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$125M	$17M	+620.7%
Gross Profit	$112M	$13M	+765.3%
Operating Income	-$292M	-$273M	-7.2%
Net Income	-$289M	-$271M	-6.6%